![Sanjay Suri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
Mr. Sanjay Suri is a Managing Director & Director at Dr. Morepen Ltd. He is on the Board of Directors at Morepen Laboratories Ltd., Blueheaven Marketing Pvt Ltd., Happier Life Pvt Ltd., Liquid Holdings Pvt Ltd., Mid-Med Financial Services & Investments Pvt Ltd., Morepen Bio Ltd., Morepen Rx Ltd., Shivalik Pesticides & Chemicals Pvt Ltd., Silver Resort Hotel India Pvt Ltd., Solace Investments & Financial Services Pvt Ltd., Solitary Investment & Financial Services Pvt Ltd., Total Care Ltd. /India/, Zios Medical Centre Pvt Ltd. and Dr. Morepen Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2025 | 3.417.240 ( 0,62 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MOREPEN LABORATORIES LIMITED | Director/Miembro de la Junta | 13/08/2019 |
Total Care Ltd. /India/ | Director/Miembro de la Junta | 30/05/2011 |
Dr. Morepen Ltd.
 Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | Director Ejecutivo | 30/05/2011 |
Silver Resort Hotel India Pvt Ltd.
 Silver Resort Hotel India Pvt Ltd. Hotels/Resorts/Cruise linesConsumer Services Owns and operates as hotels and resorts | Director/Miembro de la Junta | - |
Shivalik Pesticides & Chemicals Pvt Ltd. | Director/Miembro de la Junta | - |
Blueheaven Marketing Pvt Ltd. | Director/Miembro de la Junta | - |
Mid-Med Financial Services & Investments Pvt Ltd. | Director/Miembro de la Junta | - |
Solitary Investment & Financial Services Pvt Ltd. | Director/Miembro de la Junta | - |
Solace Investments & Financial Services Pvt Ltd. | Director/Miembro de la Junta | - |
| ░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Morepen Laboratories Ltd.
 Morepen Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures generic drugs and pharmaceutical formulations | Health Technology |
Mid-Med Financial Services & Investments Pvt Ltd. | |
Solace Investments & Financial Services Pvt Ltd. | |
Solitary Investment & Financial Services Pvt Ltd. | |
Shivalik Pesticides & Chemicals Pvt Ltd. | |
Dr. Morepen Ltd.
Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | |
Total Care Ltd. /India/ | |
Liquid Holdings Pvt Ltd.
 Liquid Holdings Pvt Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Silver Resort Hotel India Pvt Ltd.
Silver Resort Hotel India Pvt Ltd. Hotels/Resorts/Cruise linesConsumer Services Owns and operates as hotels and resorts | Consumer Services |
Blueheaven Marketing Pvt Ltd. | |
Happier Life Pvt Ltd. | |
Zios Medical Centre Pvt Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
